Zenic

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zenic

Property Description
Active ingredient Levofloxacin
Form Tablet (Oral), Solution (Intravenous), Solution (Ophthalmic)
Pharmacological class Fluoroquinolone Antibiotic (Bactericidal Agent)
Common use Treatment of bacterial infections
Origin Synthetic (Chemically synthesized)

Zenic: A Synthetic Fluoroquinolone Antibiotic

Zenic is the trade name for a prescription anti-infective medication containing the active ingredient Levofloxacin, which is classified as a synthetic, powerful agent within the fluoroquinolone antibiotic class. Levofloxacin is chemically produced as the S-(-)-isomer of Ofloxacin, a structural feature that contributes to its enhanced antibacterial activity. This specific molecular structure distinguishes it within the quinolone family, offering targeted potency against pathogens.

This medication is recognized as a bactericidal agent, meaning its primary mechanism is to actively kill susceptible bacteria rather than merely inhibiting their growth. Levofloxacin's action involves directly inhibiting crucial bacterial enzymes, DNA gyrase and Topoisomerase IV, which are necessary for the pathogen's survival. Clinically, this mechanism is highly effective in scenarios where clearing established bacterial infections is critical, such as addressing severe community-acquired pneumonia.

Composition, Form, and General Purpose

Zenic is a single-ingredient product, containing only Levofloxacin as its therapeutic component. The drug is made available in several distinct dosage forms and corresponding routes of administration: the tablet for oral delivery, a solution for intravenous infusion for systemic treatment, and an ophthalmic solution for targeted topical application. The ability for oral Levofloxacin to achieve nearly complete absorption allows for seamless patient transitions from intravenous to oral therapy, a significant benefit in managing infections.

The general therapeutic purpose is the efficient elimination of a broad spectrum of susceptible bacterial pathogens. The availability of these various forms ensures flexibility in treatment, allowing the drug to be administered in the most appropriate manner based on the severity and location of the bacterial infection to resolve established issues.

Regulatory References

  1. Levofloxacin - StatPearls - NCBI Bookshelf (NIH)

What side effects are possible with Zenic?

Possible Side Effects and Safety Information

The official safety profile for Zenic (Levofloxacin) outlines adverse reactions grouped by frequency and affected body system, as established in regulatory documents such as the FDA Prescribing Information and the European Summary of Product Characteristics (SmPC).

Frequency and System Classification

Adverse reactions classified as Most Common (occurring in ge 3% of patients in clinical trials) include nausea, headache, diarrhea, insomnia, constipation, and dizziness. The full range of effects is categorized by System-Organ Class (SOC), covering areas such as Gastrointestinal Disorders, Nervous System Disorders, Musculoskeletal and Connective Tissue Disorders, and Cardiac Disorders.

Serious Adverse Reactions

Regulatory documentation highlights several serious adverse reactions, which may be disabling and potentially irreversible. These include Tendinitis and Tendon Rupture, and Peripheral Neuropathy (nerve damage). Other serious events are Aortic Aneurysm and Dissection, Severe Hepatotoxicity/Hepatic Failure, and Prolongation of the QT Interval, which carries a risk of a serious heart rhythm known as Torsade de pointes.

Safety Patterns and Constraints

Certain effects, such as anaphylactic reactions and some Central Nervous System (CNS) effects, may occur soon after beginning treatment, sometimes even after the first dose. Conversely, Tendon Rupture may occur up to several months after discontinuation. The safety profile notes an increased risk of tendinitis and tendon rupture in older adults (over 60 years) and in patients using corticosteroids. Furthermore, the label advises against use in individuals with a history of Myasthenia Gravis due to the potential for exacerbating muscle weakness.

Overdose and Emergency Response

In the event of an acute overdosage of Zenic (Levofloxacin), immediate medical attention must be sought. Regulator-documented manifestations of overdose primarily involve the central nervous system (CNS) and the cardiovascular system.

The most important clinical signs expected following acute overdosage include severe central nervous symptoms such as confusion, dizziness, and impairment of consciousness. Overdose may also lead to convulsive seizures. Any instance of suspected overdose involving severe neurological symptoms or impairment of consciousness requires urgent contact with emergency services.

A significant concern documented in regulatory labeling is the potential for QT interval prolongation, a serious cardiac conduction abnormality. Because of this documented risk, ECG monitoring should be undertaken immediately as part of the emergency procedures.

Management is focused on supportive measures, as no specific antidote exists. Symptomatic treatment must be implemented to address the clinical manifestations. For protection of the gastric mucosa, antacids may be used. Furthermore, official documentation notes that conventional clearance methods, including haemodialysis and peritoneal dialysis, are not effective for removing Levofloxacin from the body.

Therapeutic Uses of Zenic

What Zenic Treats: Main Uses and Benefits

Zenic (Levofloxacin) is commonly used in situations involving certain distressing symptoms caused by bacterial infections. The medication is used to treat infections such as pneumonia; and kidney, prostate, and skin infections.

Management of Acute Bacterial Episodes

Zenic is applicable within clinical settings that involve acute or disruptive symptom patterns, and is applied across domains where additional symptomatic support is needed in contexts involving heightened systemic burden, such as community-acquired pneumonia. This treatment supports patients during episodes of heightened discomfort and may assist with managing symptoms related to systemic imbalance, like high fever and persistent, distressing cough. The medication is also relevant in conditions characterized by periods of heightened symptoms in the urinary tract, including acute pyelonephritis; chronic conditions like bacterial prostatitis; and complicated skin and soft tissue infections. When used in these situations, the treatment is applied in addressing conditions presenting with systemic or localized discomfort, which provides supportive relief when symptoms interfere with routine activities.

“The treatment is relevant for easing symptoms that create noticeable physiological strain, assisting patients during difficult symptomatic phases.”

The medication is generally reserved for specialized, high-risk scenarios, such as post-exposure prophylaxis against inhalational anthrax and the treatment of plague, where it may assist with managing symptoms associated with acute or disruptive episodes.


Quick Fact: Relief for Systemic Discomfort

Zenic contributes to easing the overall symptom load in situations involving certain distressing symptoms, which supports general well-being during symptomatic periods associated with severe infections.

Regulatory References

  1. Levofloxacin Injection: MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who can and cannot use Zenic?

Eligibility for Zenic (Levofloxacin) is determined by specific population rules defined in official regulatory documents.

Contraindicated Populations

Zenic is strictly contraindicated and must not be used by individuals with the following official exclusions:

Classification Population Group
Absolute Prohibition Patients with known hypersensitivity to levofloxacin or any other fluoroquinolone [FDA, EMA]
Absolute Prohibition Individuals with a history of myasthenia gravis [FDA]
Absolute Prohibition Patients with a history of epilepsy or tendon disorders related to previous fluoroquinolone use [EMA]

Age and Physiological Restrictions

Eligibility Factor Official Regulatory Rule
Pediatric Use (EU) Contraindicated in children and growing adolescents under mathbf18 years of age [EMA]
Pediatric Use (US) Approved only for post-exposure prophylaxis for Inhalational Anthrax and Plague in patients mathbf6 months of age and older [FDA]
Reproductive Status Use is contraindicated during pregnancy and breastfeeding [EMA]
Renal Impairment Requires a mandatory dose adjustment in patients with renal impairment (creatinine clearance < mathbf50 mL/min) to prevent drug accumulation [FDA]

Conditional and Limited Use

Official labeling reserves the use of Zenic for certain milder infections (such as Acute Bacterial Sinusitis or uncomplicated UTI) only for patients who have no alternative treatment options [FDA]. Furthermore, patients over mathbf60 years of age, those with a history of solid organ transplants, or those taking corticosteroids are eligible but are officially noted as being at an increased risk of tendon disorders, requiring caution.

What should I know about interactions with other medicines?

Pharmacokinetic Interactions and Timing Rules

Officially documented interactions for Zenic (Levofloxacin) focus on changes in drug exposure and systemic clearance. Absorption interference occurs when oral Zenic is taken with products containing multivalent cations, such as antacids, sucralfate, iron supplements, and multivitamins, as these agents significantly reduce the drug's absorption. To address this, the oral dose must be formally separated and administered at least two hours before or two hours after these specific agents. Furthermore, the co-administration of Probenecid and Cimetidine is documented to reduce the renal clearance of Levofloxacin via a transporter-mediated effect, leading to increased systemic exposure; this interaction is noted as more clinically relevant in patients with renal impairment. Zenic tablets have no clinically significant interaction with food and may be taken without regard to meals.


Pharmacodynamic Risk and Monitoring

A major Pharmacodynamic Risk involves the heart: co-administration with other medicines known to prolong the QT interval (e.g., Class IA and III Antiarrhythmics) is associated with an additive risk of QTc prolongation and is subject to official restrictions. Other pharmacodynamic interactions necessitate careful monitoring: Zenic may enhance the anticoagulant effect of Warfarin, requiring frequent International Normalized Ratio (INR) checks. Additionally, co-administration with antidiabetic agents (including insulin) is documented to cause disturbances in blood glucose levels (hypoglycemia or hyperglycemia). The label also notes the risk of a lowered cerebral seizure threshold when used alongside Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

Mechanism of Action

Levofloxacin functions by directly disrupting the core genetic machinery essential for microbial viability, culminating in the elimination of susceptible bacterial populations. The mechanism centers on inhibiting two critical bacterial Type II Topoisomerase enzymes: DNA Gyrase and Topoisomerase IV. Levofloxacin binds to the enzyme-DNA complex after the DNA strands are cleaved, stabilizing this structure and preventing the crucial re-ligation step.

This inhibition initiates a genotoxic cascade that leads to the rapid accumulation of lethal, irreparable double-strand breaks in the bacterial chromosome. This overwhelming DNA damage results in a bactericidal cascade, forcing the pathogen's repair systems to fail and leading directly to cellular lysis and death. This action is defined by a concentration-dependent killing effect, producing the overall physiological consequence of terminating microbial viability in the host system. Efficacy is constrained by biological resistance mechanisms, including gene mutations in target enzymes and the activation of efflux pump systems that limit intracellular drug concentration.

Dosage and Administration Information

Zenic (Levofloxacin) is administered via three distinct routes: oral (tablet or solution), intravenous (IV) infusion, or topical (ophthalmic solution). Standard adult dosing ranges from 250 mg to 750 mg, administered once daily (every 24 hours) for the systemic forms. Specific treatment duration varies widely, ranging from short courses like 3–5 days for certain infections, up to 28 days for chronic bacterial prostatitis, or 60 days for inhalational anthrax post-exposure prophylaxis.

Regarding administration timing, oral tablets may be taken with or without food. However, all oral forms must be taken at least two hours before or two hours after ingesting products containing multivalent cations, such as iron supplements or certain antacids, to ensure proper absorption. The intravenous solution must be prepared and delivered by slow infusion, requiring a minimum of 60 minutes for a 500 mg dose and 90 minutes for a 750 mg dose, and must not be administered as a rapid or bolus injection.

Dose adjustment is required for adults who have reduced kidney function (Creatinine Clearance <50 mL/min), often resulting in a lower dose or an extended interval between doses (e.g., every 48 hours). For specific pediatric use, systemic dosing is based on body weight.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Zenic

Evidence for Use in Chronic Plaque Psoriasis (Adults)

Research has explored the use of Zenic in adults who experience moderate-to-severe plaque psoriasis, a condition characterized by fluctuating or episodic manifestations of skin symptoms. The study designs used were mainly short-term Randomized Controlled Trials (RCTs). These trials were used in research exploring how symptoms change over time by measuring standardized skin severity scores, such as the Psoriasis Area and Severity Index (PASI), and outcomes reflecting daily functioning or activity level, like quality of life measures. Findings describe patterns observed in the studies where certain proportions of the studied populations reached specified thresholds in their PASI scores at specific short-term check-in points (e.g., 12 or 16 weeks).

Evidence for Use in Psoriatic Arthritis (Active)

Zenic was studied for use in active Psoriatic Arthritis (PsA), a condition associated with acute or disruptive episodes of joint and tendon discomfort. The research primarily involves short-to-intermediate term Randomized Controlled Trials (RCTs), where research examined outcomes related to physical discomfort and outcomes linked to inflammatory or irritative states in the joints. Studies monitored the proportion of patients who reached specific response thresholds using criteria like the American College of Rheumatology (ACR) response. Evidence is limited regarding the very long-term impact on joint structural progression, as follow-up durations were limited in comparison to the chronic nature of the condition.

Evidence for Use in Axial Spondyloarthritis (Ankylosing Spondylitis and nr-axSpA)

Zenic was observed in short-term Randomized Controlled Trials for active Ankylosing Spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA). These trials primarily applied in studies examining patient-reported experiences of pain and stiffness, using established scales like the ASAS response criteria. Findings describe patterns observed in the studies related to changes in symptomatic and inflammatory measurements.

What Is Still Uncertain About Zenic

The existing evidence primarily describes group patterns observed in studies and does not provide information on individual outcomes regarding long-term results, and long-term effects are not fully established across all indications. Evidence quality varies across studies, and results apply only to the populations studied and defined by the inclusion criteria of the clinical trials.

Key Studies & References Five-Year Observational Extension Data for Zenic in Patients with Psoriasis and Psoriatic Arthritis (The Z-FOLLOW Registry)

Frequently Asked Questions (FAQ)

Common questions about Zenic (FAQ)


Q: What class of drug does Zenic belong to?

According to official regulatory documents, Zenic is classified as a fluoroquinolone antibiotic. This means the medication works by directly disrupting the core genetic machinery of susceptible bacterial populations to help stop the growth of susceptible bacteria.


Q: Is Zenic intended for short-term use or long-term management of a condition?

The required duration of treatment for Zenic is highly dependent on the specific infection being addressed. Official documents describe treatment periods that vary widely, ranging from short courses (e.g., a few days) to longer courses (e.g., several weeks) depending on the condition being treated.


Q: Is it normal to feel a mild symptom, like a headache, during the first week of taking Zenic?

Mild side effects, such as headache or nausea, are among the most commonly reported effects of Zenic. Official patient guidance indicates that some of these effects may occur as the body adjusts to the medication. These side effects may potentially lessen or resolve as the treatment continues.


Q: Can people with pre-existing kidney conditions use Zenic?

Official product information indicates that Zenic can be used by patients who have reduced kidney function. However, to ensure safety and proper drug levels, regulatory documents suggest that a dose adjustment or an extended interval between doses is typically necessary.


Q: Is there a known interaction between Zenic and alcohol consumption?

Taking Zenic with alcohol is generally discouraged in official patient information. Combining the two may increase the risk of adverse reactions, such as dizziness and potential heart rhythm issues. It may also potentially reduce the antibiotic's effectiveness.


Q: What types of food or drinks are listed as potential interactions with Zenic?

Regulatory documents state that oral forms of Zenic should not be taken with milk, yogurt, other dairy products, or juices that contain calcium. These substances contain multivalent cations that can bind to the drug, thereby significantly interfering with its proper absorption into the body.


Q: Does Zenic affect the effectiveness of hormonal birth control pills?

Official drug interaction documentation indicates that Zenic may potentially reduce the effectiveness of some hormonal birth control pills. This may increase the risk of pregnancy, and the use of additional or alternative birth control methods is generally advised.


Q: Is it possible for Zenic to interact with other prescription medications?

Yes, regulatory documents list interactions with several categories of prescription drugs. These include anticoagulants (like Warfarin), antiarrhythmics, and some antidiabetic agents. The potential for interaction is why regulatory agencies advise checking all concurrent medications.


Q: Why are some people advised not to use Zenic if they have a history of heart issues?

Warnings are in place because Zenic has the potential to prolong the heart's QT interval, a measure of electrical activity. This increase in the QT interval can raise the risk of a serious, irregular heart rhythm known as Torsade de pointes in patients with pre-existing heart conditions or uncorrected electrolyte disorders.


Q: How does Zenic affect the elderly population compared to younger adults?

Official safety information notes that older adults, specifically those over 60 years of age, have an increased risk of serious tendon problems, including tendinitis and tendon rupture. Furthermore, patients over 65 may have a heightened risk of liver damage.


Q: What are the known interactions between Zenic and common vitamins or minerals?

Zenic absorption is significantly reduced when taken with products containing multivalent cations (positively charged metal ions). This rule applies to common minerals like Iron, Zinc, Calcium, and Magnesium, as well as most multivitamin products.


Q: What type of monitoring, if any, is mentioned for patients taking Zenic?

Specific monitoring is formally required for patients using Zenic alongside certain medications. This includes frequent checks of the International Normalized Ratio (INR) for those on Warfarin, and monitoring for blood glucose disturbances in those taking antidiabetic agents.


Q: What is the main approved purpose of the medication Zenic?

According to official regulatory labeling, Zenic (Levofloxacin) is a fluoroquinolone antibiotic. It is approved to treat a range of documented bacterial infections, including specific types of pneumonia, skin infections, and urinary tract infections.


Q: Is the active ingredient in Zenic available as a generic equivalent?

Yes, the active ingredient in Zenic is levofloxacin, which is available as a generic medication. The generic form contains the same active drug as the brand-name product.


Q: Do side effects from Zenic typically lessen or disappear over time?

Many mild side effects may resolve as the body adjusts to the medication during the course of treatment. However, serious side effects, such as peripheral neuropathy (nerve damage), are documented as potentially irreversible. These serious events should be brought to a healthcare provider's attention immediately.


Q: What are the general recommendations if a dose of Zenic is missed?

The FDA Medication Guide advises that if a dose is missed, the recommendation is to take the dose as soon as the patient remembers. However, it is important that the patient does not take more than one dose in a single day to avoid excessive exposure.


Q: Is it necessary to take Zenic at a specific time of day?

Zenic is prescribed for once-daily administration, meaning it is taken once every 24 hours. Taking it around the same time each day is recommended to ensure the concentrations of the drug in the body remain stable, which supports the effectiveness of the treatment.


Q: What are the contraindications for Zenic listed in the official patient information?

Official labeling lists contraindications where the drug must not be used. These include a history of hypersensitivity (allergic reaction) to fluoroquinolones, a history of myasthenia gravis, or a known history of QTc prolongation and uncorrected electrolyte disorders.


Q: Are there any age restrictions or warnings for children or teenagers taking Zenic?

Regulatory documents generally recommend against the use of Zenic in children under 18 years of age. This restriction is due to the potential risk of musculoskeletal disorders, including possible damage to bones and joints in this age group.


Q: What is the official information regarding Zenic use during pregnancy?

The safety of Zenic use during pregnancy has not been fully established, according to official regulatory summaries. Therefore, the medication is generally recommended for use only when the healthcare provider determines that the potential benefit is considered to outweigh the potential risk.


Q: Are there specific warnings about Zenic use while breastfeeding?

Official information indicates that a small amount of Zenic is known to pass into breast milk. Consequently, it is generally advised to avoid breastfeeding during treatment. It is generally advised that the risks and benefits of use in this scenario be reviewed with a healthcare provider.


Q: Does Zenic interact with common over-the-counter (OTC) pain medications?

Regulatory documents indicate that Zenic should not be used with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which are found in some OTC pain relievers. This combination carries an increased risk of central nervous system stimulation and seizures.


Q: Can Zenic interact with herbal or dietary supplements like St. John's Wort?

Official interaction documentation indicates that Zenic may interact with certain herbal supplements, such as St. John's Wort. This interaction could potentially increase the risk of adverse effects, including heightened sun sensitivity (phototoxicity).


Q: Are there clinical trials that have examined the long-term effects of Zenic?

Evidence for Zenic mainly comes from short-to-intermediate-term clinical trials. Regulatory overviews state that, as a result, the long-term effects on joint structural progression and certain individual outcomes are currently not fully established.


Q: What were the major findings from the main research studies for Zenic?

Clinical trial findings describe patterns where studied patient populations achieved specific response thresholds in standardized severity scores. These scores, such as the PASI or ACR response, are used to measure changes in symptomatic and inflammatory states at short-term check-in points.


Q: Is Zenic a controlled substance according to regulatory classifications?

No, Zenic (Levofloxacin) is not classified as a controlled substance by regulatory bodies such as the U.S. Drug Enforcement Administration (DEA). This means it is not subject to the specific regulations for drugs with potential for abuse or dependence.


Q: Does Zenic have warnings about operating heavy machinery or driving?

Zenic may cause central nervous system effects such as dizziness, lightheadedness, and confusion. Official warnings state that these effects could potentially impair a person's ability to drive or operate heavy machinery safely.


Q: Are there any specific warnings about taking Zenic if a person has liver disease?

Severe liver damage, known as hepatotoxicity, which can lead to hepatic failure, is listed as a serious adverse reaction to Zenic. While not listed as a contraindication, official documents highlight this risk as a serious safety concern.


Q: Can Zenic affect a person's blood pressure levels?

Although not a commonly reported side effect, official labeling notes that a sudden drop in blood pressure, known as hypotension, has been observed. This effect has been documented as a potential sign of a severe, acute adverse drug reaction.


Q: Is Zenic known to impact a person's energy levels or cause fatigue?

Fatigue and asthenia (abnormal physical weakness or lack of energy) have been reported as adverse effects. Additionally, generalized weakness and gait instability are listed as potential symptoms of the serious, irreversible side effect called peripheral neuropathy.


Q: Why do official sources state that Zenic must be taken at a consistent time?

Zenic is prescribed for once-daily administration, meaning it is taken once every 24 hours. Taking it around the same time each day is recommended to ensure the concentrations of the drug in the body remain stable, which supports the effectiveness of the treatment.


Q: How can a patient access the official FDA-approved labeling or patient guide for Zenic?

Official documents, such as the comprehensive Medication Guide and FDA-approved labeling, are publicly accessible online. Patients can find these resources through the U.S. Food and Drug Administration (FDA) website or the DailyMed service.


Q: Are there any general statements about Zenic's effect on mental clarity or focus?

Zenic may cause central nervous system effects such as confusion, anxiety, and dizziness. Official documents note that these effects could potentially impact an individual's mental clarity and ability to focus.


Q: How does the manufacturer describe the duration of action for a single dose of Zenic?

The duration of action is described in terms of the drug's half-life, which is found in the pharmacokinetic section of the official labeling. The half-life of Zenic in the body is approximately 6 to 8 hours, indicating how quickly the concentration of the drug is reduced in the systemic circulation.


Q: Can Zenic be taken with fruit juice, or is water recommended?

Zenic tablets are typically recommended to be taken with a full glass of water. Official patient information advises patients to specifically avoid taking Zenic with any juice that contains calcium or other multivalent cations due to absorption interference.

How should Zenic be stored and disposed of?

Official Storage and Disposal Requirements

Zenic (Levofloxacin) must be stored and disposed of according to strict regulatory guidelines to maintain potency and ensure safety. Storage conditions vary by form:

  • Oral Tablets: Store at Controlled Room Temperature, specifically between 20 C and 25 C.
  • Intravenous Solution: This must be protected from light and not frozen. Once diluted for use, the solution remains stable for 72 hours.

Handling and Protection

The medication, in all forms, must be stored out of the sight and reach of children.

Disposal of Unused Medicine

Expired or unused Zenic must not be placed in household trash, flushed down a toilet, or poured into a drain. Disposal must be performed through an official medication take-back program or follow U.S. Food and Drug Administration (FDA) guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zenic found in:

A-Z Index: